NR3C1 and urinary bladder cancer: However, Dex increases glucocorticoid receptor (GR)-mediated reporter activity and cell proliferation while inhibiting apoptosis and cell invasion by suppressing the expression of MMP-2/ MMP-9, IL-6 and inducing mesenchymal-to-epithelial transition (MET) in human bladder cancer lines [11].